title: Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
authors.affiliation: Department of Urology, University of Amsterdam, The Netherlands.
authors.forename: K H
authors.initials: KH
authors.lastname: Kurth
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
authors.forename: M
authors.initials: M
authors.lastname: de Pauw
authors.forename: F
authors.initials: F
authors.lastname: ten Kate
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D006801:Humans; D009361:Neoplasm Invasiveness; D011379:Prognosis; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents